Mario L. Marques‐Piubelli
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Salivary Gland Tumors Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Research and Treatments
Most-Cited Works
- → Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy(2021)128 cited
- → Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression(2022)96 cited
- → EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management(2022)72 cited
- → Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review(2019)63 cited
- → PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer(2021)56 cited
- → Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses(2022)54 cited
- → Spontaneous tumor regression following COVID-19 vaccination(2022)53 cited
- → Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction(2021)48 cited
- → Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma(2023)46 cited
- → Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship(2021)41 cited